STAT1, NF-κB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes

Molecular Metabolism

Volumn 2, Issue 3, 2013, Pages 161-170

  Zhao, Peng ^a,b   Stephens, Jacqueline Marie ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipocyte; ERKs; IFN ; Lipocalin 2; NF B; STAT1; TNF

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RELEASE; DNA PURIFICATION; ENZYME SPECIFICITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 84883248810     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.04.003     Document Type: Article

References (39)

1. Hotamisligil G.S. Molecular mechanisms of insulin resistance and the role of the adipocyte. International Journal of Obesity and Related Metabolic Disorders 2000, 24(Suppl. 4):S23-S27.
2. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004, 89:2548-2556.
3. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
4. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
5. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003, 112:1821-1830.
6. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
7. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., Libby P. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circulation Research 2008, 103:467-476.
8. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
9. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
10. McGillicuddy F.C., Chiquoine E.H., Hinkle C.C., Kim R.J., Shah R., Roche H.M., Smyth E.M., Reilly M.P. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. Journal of Biological Chemistry 2009, 284:31936-31944.
11. Hu J., Roy S.K., Shapiro P.S., Rodig S.R., Reddy S.P., Platanias L.C., Schreiber R.D., Kalvakolanu D.V. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. Journal of Biological Chemistry 2001, 276:287-297.
12. Peraldi P., Xu M., Spiegelman B.M. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. Journal of Clinical Investigation 1997, 100:1863-1869.
13. Vietor I., Schwenger P., Li W., Schlessinger J., Vilcek J. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. Journal of Biological Chemistry 1993, 268:18994-18999.
14. Cowan S.W., Newcomer M.E., Jones T.A. Crystallographic refinement of human serum retinol binding protein at 2A resolution. Proteins 1990, 8:44-61.
15. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. Journal of Biological Chemistry 1993, 268:10425-10432.
16. Nelson A.L., Barasch J.M., Bunte R.M., Weiser J.N. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cellular Microbiology 2005, 7:1404-1417.
17. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
18. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Molecular Cell 2002, 10:1033-1043.
19. Jessen B.A., Stevens G.J. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts. Gene 2002, 299:95-100.
20. Yan Q.W., Yang Q., Mody N., Graham T.E., Hsu C.H., Xu Z., Houstis N.E., Kahn B.B., Rosen E.D. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 56:2533-2540.
21. Catalan V., Gomez-Ambrosi J., Rodriguez A., Ramirez B., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J., Fruhbeck G. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. Journal of Molecular Medicine 2009, 87:803-813.
22. Wang Y., Lam K.S., Kraegen E.W., Sweeney G., Zhang J., Tso A.W., Chow W.S., Wat N.M., Xu J.Y., Hoo R.L., Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical Chemistry 2007, 53:34-41.
23. Zhang J., Wu Y., Zhang Y., Leroith D., Bernlohr D.A., Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Molecular Endocrinology 2008, 22:1416-1426.
24. Guo H., Jin D., Zhang Y., Wright W., Bazuine M., Brockman D.A., Bernlohr D.A., Chen X. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 2010, 59:1376-1385.
25. Law I.K., Xu A., Lam K.S., Berger T., Mak T.W., Vanhoutte P.M., Liu J.T., Sweeney G., Zhou M., Yang B., Wang Y. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010, 59:872-882.
26. Jun L.S., Siddall C.P., Rosen E.D. A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. American Journal of Physiology-Endocrinology and Metabolism 2011, 301:E825-E835.
27. Nohara A., Okada S., Ohshima K., Pessin J.E., Mori M. Cyclin-dependent kinase-5 is a key molecule in tumor necrosis factor-alpha-induced insulin resistance. Journal of Biological Chemistry 2011, 286:33457-33465.
28. Waite K.J., Floyd Z.E., Arbour-Reily P., Stephens J.M. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. Journal of Biological Chemistry 2001, 276:7062-7068.
29. Zvonic S., Story D.J., Stephens J.M., Mynatt R.L. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo. Biochemical and Biophysical Research Communications 2003, 302:359-362.
30. Sommer G., Weise S., Kralisch S., Lossner U., Bluher M., Stumvoll M., Fasshauer M. Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro. Journal of Cellular Biochemistry 2009, 106:103-108.
31. Zerega B., Cermelli S., Michelis B., Cancedda R., Cancedda F.D. Expression of NRL/NGAL (neu-related lipocalin/neutrophil gelatinase-associated lipocalin) during mammalian embryonic development and in inflammation. European Journal of Cell Biology 2000, 79:165-172.
32. Garay-Rojas E., Harper M., Hraba-Renevey S., Kress M. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 1996, 170:173-180.
33. Tan B.K., Adya R., Shan X., Syed F., Lewandowski K.C., O'Hare J.P., Randeva H.S. Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care 2009, 32:129-131.
34. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250.
35. Hu J., Nakano H., Sakurai H., Colburn N.H. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 2004, 25:1991-2003.
36. Mandrekar P., Jeliazkova V., Catalano D., Szabo G. Acute alcohol exposure exerts anti-inflammatory effects by inhibiting IkappaB kinase activity and p65 phosphorylation in human monocytes. Journal of Immunology 2007, 178:7686-7693.
37. Vermeulen L., De W.G., Van D.P., Vanden Berghe W., Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO Journal 2003, 22:1313-1324.
38. Mattioli I., Geng H., Sebald A., Hodel M., Bucher C., Kracht M., Schmitz M.L. Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. Journal of Biological Chemistry 2006, 281:6175-6183.
39. Mattioli I., Sebald A., Bucher C., Charles R.P., Nakano H., Doi T., Kracht M., Schmitz M.L. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. Journal of Immunology 2004, 172:6336-6344.